LEXAGNE HOLDINGS WKN: A2ATW9 ISIN: CA52886L1031 Kürzel: 5XS2 Forum: Aktien Thema: Hauptdiskussion

https://www.globenewswire.com/news-release/2021/08/12/2279688/0/en/LexaGene-Demonstrates-a-Simple-and-Inexpensive-Multiplex-PCR-Chemistry-with-Shorter-Lead-Times-for-use-on-its-MiQLab-System.html

Und wieder sind wir auf Start zurück!

https://www.streetinsider.com/dr/news.php?id=18903503

https://www.globenewswire.com/news-release/2021/09/16/2298338/0/en/LexaGene-Enters-into-Cooperative-Research-and-Development-Agreement-with-the-United-States-Army-s-Combat-Capabilities-Development-Command.html

https://www.globenewswire.com/news-release/2021/07/20/2265550/0/en/LexaGene-s-MiQLab-Detects-Common-Bioreactor-Contaminant-up-to-300-Times-Faster-than-Conventional-Methods.html

.....ist wenn FDA und EUA Approval für Human kommt. Damit ganz anderer Sales Ausblick ....dann!

Irgendwann.......

LexaGene Launches 2nd Generation Bacterial and Drug Resistance Test to Better Meet the Diagnostic Needs of Veterinarians https://www.globenewswire.com/news-release/2021/07/07/2258874/0/en/LexaGene-Launches-2nd-Generation-Bacterial-and-Drug-Resistance-Test-to-Better-Meet-the-Diagnostic-Needs-of-Veterinarians.html

LexaGene Advances Towards FDA Emergency Use Authorization https://lexagene.com/release/2021/lexagene-advances-towards-fda-emergency-use-authorization/

LexaGene Engages LHS as Integrated Investor and Public Relations Agency of Record

https://lexagene.com/release/2021/lexagene-engages-lhs-as-integrated-investor-and-public-relations-agency-of-record/

https://www.globenewswire.com/news-release/2021/06/24/2252501/0/en/New-Sale-of-LexaGene-s-MiQLab-System-Propels-Early-Diagnostic-Testing-in-Veterinarian-Practices.html

LexaGene Closes Sale to Alpine Veterinary Hospital https://www.globenewswire.com/news-release/2021/06/14/2246451/0/en/LexaGene-Closes-Sale-to-Alpine-Veterinary-Hospital.html

News betreffend langsam wachsender Bakterien Stämmen und Open Access de MiQLabs... https://lexagene.com/release/2021/detects-acnes-36-times-faster-increase-vaccine-safety-supply/?utm_campaign=Investors&utm_content=169345153&utm_medium=social&utm_source=twitter&hss_channel=tw-839599015024943104 Und mit Video Interview von Jack Regan CEO von Lexagene https://ca.proactiveinvestors.com/companies/amp/news/951985